Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use

Journal of Cataract and Refractive Surgery

Volumn 34, Issue 12, 2008, Pages 2139-2145

  Yoeruek, Efdal ^a   Spitzer, Martin S ^a   Saygili, Oguzhan ^a   Tatar, Olcay ^a   Biedermann, Tilo ^a   Yoeruek, Erdal ^a   Bartz Schmidt, Karl U ^a   Szurman, Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CEFUROXIME; LIPOCORTIN 5; PROPIDIUM IODIDE; VANCOMYCIN;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG SAFETY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 56649106512     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.08.022     Document Type: Article

References (29)

1. Montan P., Lundström M., Stenevi U., and Thorburn W. Endophthalmitis following cataract surgery in Sweden. The 1998 national prospective survey. Acta Ophthalmol Scand 80 (2002) 258-261
2. Mayer E., Cadman D., Ewings P., Twomey J.M., Gray R.H., Claridge K.G., Hakin K.N., and Bates A.K. A 10 year retrospective survey of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis. Br J Ophthalmol 87 (2003) 867-869
3. Desai P. The National Cataract Surgery Survey: II. Clinical outcomes. Eye 7 (1993) 489-494
4. Khan R.I., Kennedy S., and Barry P. Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997-2001). J Cataract Refract Surg 31 (2005) 1575-1581
5. Ciulla T.A., Starr M.B., and Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology 109 (2002) 13-24
6. Speaker M.G., Milch F.A., Shah M.K., Eisner W., and Kreiswirth B.N. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98 (1991) 639-649 discussion by J Baum, 650
7. Han D.P., Wisniewski S.R., Wilson L.A., Barza M., Vine A.K., Doft B.H., and Kelsey S.F. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study; the Endophthalmitis Vitrectomy Study Group. Am J Ophthalmol 122 (1996) 1-17 correction, 920
8. Dickey J.B., Thompson K.D., and Jay W.M. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol 112 (1991) 278-282
9. Montan P.G., Wejde G., Koranyi G., and Rylander M. Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 28 (2002) 977-981
10. Montan P.G., Wejde G., Setterquist H., Rylander M., and Zetterström C. Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28 (2002) 982-987
11. Libre P.E., Della-Latta P., and Chin N.-X. Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model. J Cataract Refract Surg 29 (2003) 1791-1794
12. Murphy C.C., Nicholson S., Quah S.A., Batterbury M., Neal T., and Kaye S.B. Pharmacokinetics of vancomycin following intracameral bolus injection in patients undergoing phacoemulsification cataract surgery. Br J Ophthalmol 91 (2007) 1350-1353
13. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33 (2007) 978-988
14. Chang C.-H., Lin C.-P., and Wang H.-Z. Cytotoxicity of intracameral injection drugs to corneal endothelium as evaluated by corneal endothelial cell culture. Cornea 14 (1995) 71-76
15. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 184 (1995) 39-51
16. Taban M., Behrens A., Newcomb R.L., Nobe M.Y., Saedi G., Sweet P.M., and McDonnell P.J. Acute endophthalmitis following cataract surgery; a systematic review of the literature. Arch Ophthalmol 123 (2005) 613-620
17. Olson R.J. Reducing the risk of postoperative endophthalmitis. Surv Ophthalmol 49 suppl 2 (2004) S55-S61
18. Peyman G.A., Sathar M.L., and May D.R. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol 61 (1977) 260-262
19. Chalkley T., and Shock D. Prophylactic intraocular antibiotics in cataract surgery. Trans Am Ophthalmol Soc 69 (1971) 200-207. discussion, 207-209. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1310414&blobty pe=pdf Accessed September 7, 2008
20. Kane A., Barza M., and Baum J. Intravitreal injection of gentamicin in rabbits; effect of inflammation and pigmentation on half-life and ocular distribution. Invest Ophthalmol Vis Sci 20 (1981) 593-597. http://www.iovs.org/cgi/reprint/20/5/593 Accessed September 7, 2008
21. Campochiaro P.A., and Green W.R. Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol 110 (1992) 1625-1629
22. Lanbeck P., and Paulsen O. Short-term effects of four antibiotics on DNA synthesis in endothelial cells. Pharmacol Toxicol 88 (2001) 204-208
23. Gimbel H.V., and Sun R. Prophylactic intracameral vancomycin and CME. [letter]. Ophthalmology 107 (2000) 1614-1615
24. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study; a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113 (1995) 1479-1496
25. Benz M.S., Scott I.U., Flynn Jr. H.W., Unonius N., and Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 137 (2004) 38-42
26. Yoeruek E., Spitzer M.S., Tatar O., Biedemann T., Grisanti S., Lüke M., Bartz-Schmidt K.U., and Szurman P. Toxic effects of recombinant tissue plasminogen activator on cultured human corneal endothelial cells. Invest Ophthalmol Vis Sci 49 (2008) 1392-1397
27. Yoeruek E., Spitzer M.S., Tatar O., Aisenbrey S., Bartz-Schmidt K.U., and Szurman P. Safety profile of bevacizumab on cultured human corneal cells. Cornea 26 (2007) 977-982
28. Murphy C., Alvarado J., Juster R., and Maglio M. Prenatal and postnatal cellularity of the human corneal endothelium; a quantitative histologic study. Invest Ophthalmol Vis Sci 25 (1984) 312-322. http://www.iovs.org/cgi/reprint/25/3/312.pdf Accessed September 7, 2008
29. Cho K.S., Lee E.H., Choi J.S., and Joo C.K. Reactive oxygen species induced apoptosis and necrosis in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 40 (1999) 911-919. http://www.iovs.org/cgi/reprint/40/5/911 Accessed September 7, 2008